Esther Troost
Esther Troost
Resident in Radiation Oncology
Dirección de correo verificada de
Citado por
Citado por
The image biomarker standardization initiative: standardized quantitative radiomics for high-throughput image-based phenotyping
A Zwanenburg, M Vallières, MA Abdalah, HJWL Aerts, V Andrearczyk, ...
Radiology 295 (2), 328-338, 2020
The effect of SUV discretization in quantitative FDG-PET Radiomics: the need for standardized methodology in tumor texture analysis
RTH Leijenaar, G Nalbantov, S Carvalho, WJ Van Elmpt, EGC Troost, ...
Scientific reports 5 (1), 11075, 2015
A comparative study of machine learning methods for time-to-event survival data for radiomics risk modelling
S Leger, A Zwanenburg, K Pilz, F Lohaus, A Linge, K Zöphel, J Kotzerke, ...
Scientific reports 7 (1), 13206, 2017
Rapid Learning health care in oncology’–an approach towards decision support systems enabling customised radiotherapy
P Lambin, E Roelofs, B Reymen, ER Velazquez, J Buijsen, CML Zegers, ...
Radiotherapy and Oncology 109 (1), 159-164, 2013
Assessing robustness of radiomic features by image perturbation
A Zwanenburg, S Leger, L Agolli, K Pilz, EGC Troost, C Richter, S Löck
Scientific reports 9 (1), 614, 2019
18F-FLT PET/CT for early response monitoring and dose escalation in oropharyngeal tumors
EGC Troost, J Bussink, AL Hoffmann, OC Boerman, WJG Oyen, ...
Journal of Nuclear Medicine 51 (6), 866-874, 2010
18F-FLT PET does not discriminate between reactive and metastatic lymph nodes in primary head and neck cancer patients
EGC Troost, WV Vogel, MAW Merkx, PJ Slootweg, HAM Marres, ...
Journal of nuclear medicine 48 (5), 726-735, 2007
Residual tumour hypoxia in head-and-neck cancer patients undergoing primary radiochemotherapy, final results of a prospective trial on repeat FMISO-PET imaging
S Löck, R Perrin, A Seidlitz, A Bandurska-Luque, S Zschaeck, K Zöphel, ...
Radiotherapy and Oncology 124 (3), 533-540, 2017
18F-FDG PET early response evaluation of locally advanced non–small cell lung cancer treated with concomitant chemoradiotherapy
EA Usmanij, LF de Geus-Oei, EGC Troost, L Peters-Bax, ...
Journal of Nuclear Medicine 54 (9), 1528-1534, 2013
Relative biological effectiveness in proton beam therapy–Current knowledge and future challenges
A Lühr, C von Neubeck, M Krause, EGC Troost
Clinical and translational radiation oncology 9, 35-41, 2018
18F-FLT PET during radiotherapy or chemoradiotherapy in head and neck squamous cell carcinoma is an early predictor of outcome
BAW Hoeben, EGC Troost, PN Span, CML van Herpen, J Bussink, ...
Journal of Nuclear Medicine 54 (4), 532-540, 2013
Evaluation of tumour hypoxia during radiotherapy using [18F]HX4 PET imaging and blood biomarkers in patients with head and neck cancer
CML Zegers, FJP Hoebers, W van Elmpt, JA Bons, MC Öllers, EGC Troost, ...
European journal of nuclear medicine and molecular imaging 43, 2139-2146, 2016
Radiation dose constraints for organs at risk in neuro-oncology; the European Particle Therapy Network consensus
M Lambrecht, DBP Eekers, C Alapetite, NG Burnet, V Calugaru, ...
Radiotherapy and Oncology 128 (1), 26-36, 2018
PET of hypoxia with 89Zr-labeled cG250-F (ab′) 2 in head and neck tumors
BAW Hoeben, JHAM Kaanders, GM Franssen, EGC Troost, PFJW Rijken, ...
Journal of Nuclear Medicine 51 (7), 1076-1083, 2010
Clinical evidence on PET–CT for radiation therapy planning in head and neck tumours
EGC Troost, DAX Schinagl, J Bussink, WJG Oyen, JHAM Kaanders
Radiotherapy and Oncology 96 (3), 328-334, 2010
Additional PET/CT in week 5–6 of radiotherapy for patients with stage III non-small cell lung cancer as a means of dose escalation planning?
C Gillham, D Zips, F Pönisch, C Evers, W Enghardt, N Abolmaali, ...
Radiotherapy and Oncology 88 (3), 335-341, 2008
Correlation of [18F]FMISO autoradiography and pimonodazole immunohistochemistry in human head and neck carcinoma xenografts
EGC Troost, P Laverman, MEP Philippens, J Lok, AJ van der Kogel, ...
European journal of nuclear medicine and molecular imaging 35, 1803-1811, 2008
In Vivo Quantification of Hypoxic and Metabolic Status of NSCLC Tumors Using [18F]HX4 and [18F]FDG-PET/CT Imaging
CML Zegers, W Van Elmpt, B Reymen, AJG Even, EGC Troost, MC Öllers, ...
Clinical Cancer Research 20 (24), 6389-6397, 2014
PET in the management of locally advanced and metastatic NSCLC
W Grootjans, LF de Geus-Oei, EGC Troost, EP Visser, WJG Oyen, ...
Nature reviews Clinical oncology 12 (7), 395-407, 2015
Radiotherapy combined with the immunocytokine L19-IL2 provides long-lasting antitumor effects
CML Zegers, NH Rekers, DHF Quaden, NG Lieuwes, A Yaromina, ...
Clinical cancer research 21 (5), 1151-1160, 2015
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20